Cision PR Newswire
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Homology Medicines, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 24, 2022 - (NASDAQ: FIXX)
News provided byThe Gross Law Firm
May 11, 2022, 5:45 AM ET
NEW YORK, May 11, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Homology Medicines, Inc..
Shareholders who purchased shares of FIXX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.
CONTACT US HERE:
CLASS PERIOD: June 10, 2019 to February 18, 2022
ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) the Company had overstated the efficacy and risk mitigation of its lead product candidate, HMI-102; (ii) accordingly, it was unlikely that the Company would be able to commercialize HMI102 in its present form; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.
DEADLINE: May 24, 2022 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/homology-medicines-inc-loss-submission-form/?id=27025&from=4
NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of FIXX during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is May 24, 2022. There is no cost or obligation to you to participate in this case.
WHY GROSS LAW FIRM? The Gross Law Firm is nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Phone: (646) 453-8903
View original content:https://www.prnewswire.com/news-releases/shareholder-alert-the-gross-law-firm-notifies-shareholders-of-homology-medicines-inc-of-a-class-action-lawsuit-and-a-lead-plaintiff-deadline-of-may-24-2022--nasdaq-fixx-301544493.html
SOURCE The Gross Law Firm